Quantitative analysis of vascular endothelial growth factor in primary breast cancer

Cancer

Volumn 77, Issue 6, 1996, Pages 1101-1106

  Toi, Masakazu ^a   Kondo, Shinichi ^b   Suzuki, Hideo ^b   Yamamoto, Yutaka ^a   Inada, Kazuo ^a   Imazawa, Takashi ^a   Taniguchi, Tadaaki ^a   Tominaga, Takeshi ^a  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^b Base Technology Center   (Japan)

Author keywords

basic FGF; breast cancer; HGF; VEGF

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; SCATTER FACTOR; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BREAST CANCER; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; NEOVASCULARIZATION (PATHOLOGY); PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE DIAGNOSIS; VASCULAR ENDOTHELIUM;

BREAST NEOPLASMS; ENDOTHELIAL GROWTH FACTORS; FEMALE; FIBROBLAST GROWTH FACTOR 2; HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNOENZYME TECHNIQUES; NEOVASCULARIZATION, PATHOLOGIC;

EID: 0029985805     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960315)77:6<1101::AID-CNCR15>3.0.CO;2-5     Document Type: Article

References (28)

1. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992;84:1875-87.
2. Horak ER, Leek R, Klenk N, Lejeune S, Smith K, Stuart N, et al. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 1992;340:1120-4.
3. Toi M, Kashitani J, Tominaga T. Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int J Cancer 1993;55:371-4.
4. Gasparini G, Weidner N, Bevilacqua P, Maluta S, Palma PD, Caffo O, et al. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol 1994;12:454-66.
5. Gasparini G, Harris AL. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J Clin Oncol 1995;13:765-82.
6. Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989;161:851-8.
7. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983;219:983-5.
8. Esch F, Baird A, Ling N, Ueno N, Hill F, Deneroy L, et al. Primary structure of bovine basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF. Proc Natl Acad Sci USA 1985;82:6507-11.
9. Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatomized rats. Biochem Biophys Res Commun 1984;122: 1450-9.
10. Toi M, Hoshina S, Takayanagi T, Tominaga T. Association of vascular endothelial growth factor expression with tumor angiogenesis and early response in primary breast cancer. Jpn J Cancer Res 1994;85:1045-9.
11. Toi M, Inada K, Suzuki H, Tominaga T. Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Br J Cancer Res Treat 1995;36:193-204.
12. Anandappa SY, Winstanley JHR, Leinster S, Green B, Rundland PS, Barraclough R. Comparative expression of fibroblast growth factor mRNA in benign and malignant breast disease. Br J Cancer 1994;69:772-6.
13. Yamashita J, Ogawa M, Yamashita S, Nomura K, Kuramoto M, Saishoji T, et al. Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. Cancer Res 1994;54:1630-3.
14. Ferrara N, Houck KA, Jakeman LB, Winer J, Leung DW. The vascular endothelial growth factor family of polypeptides. J Cell Biochem 1991;47:211-8.
15. Hanatani M, Tanaka Y, Kondo S, Ohmori I, Suzuki H. Sensitive chemiluminescence enzyme immunoassay for vascular endothelial growth factor/vascular permeability factor in human serum. Biosci Biotechnol Biochem 1995;59:1958-9.
16. Risau W. Angiogenic growth factors. Proc Growth Factor Res 1990;2:71-9.
17. Plate KH, Breier G, Risau W. Molecular mechanism of development and tumor angiogenesis. Brain Pathol 1994;4:207-18.
18. Grant DS, Kleiman HK, Goldberg ID, Bhargava MM, Ickoloff BJ, Kissella JL, et al. Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci USA 1993;90:1937-41.
19. Bussolino F, Di Renzo MF, Ziche M, Boochietto E, Olivero M, Naldini L, et al. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 1992;119:629-41.
20. Naldini L, Tamagnone L, Viga E. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J 1992;11:4825-33.
21. Wendy M, Zarnegar R, Michalopoulos K. Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA. Am J Pathol 1993;143:949-58.
22. Briozzo P, Badet J, Capony F, Pieri I, Montcourrier P, Barritault D, et al. MCF-7 mammary carcinoma cells respond to bFGF and internalize it following its release from extracellular matrix: a permissive role of cathepsin D. Exp Cell Res 1991;194:252-9.
23. Saksela O, Rifkin DB. Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. J Cell Biol 1990; 110:767-75.
24. Ingber D, Fujita T, Kashimoto S, Sudo K, Kanamaru T, Berm H, et al. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth. Nature 1990;348:555-7.
25. Folkman J. Aniogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1995;1:27-31.
26. Holmgren L, O'Reilly MS, Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med 1995;1: 149-53.
27. Kim KJ, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 1993;362:841-4.
28. Kondo S, Asano M, Suzuki H. Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody. Biochem Biophys Res Commun 1993;194:1234-41.